State of Health podcast

CRISPR-Based Therapy for Hereditary Angioedema

11/19/2024
0:00
4:05
Rewind 15 seconds
Fast Forward 15 seconds

Explore groundbreaking advancements in treating hereditary angioedema with NTLA 2002, a revolutionary CRISPR-Cas9 therapy. Discover how this innovative one-time treatment significantly reduces attacks, offering hope for those affected by this rare condition. Original Article here.


ABOUT THE STATE OF HEALTH

The State of Health helps you understand the most important news and research in healthcare and medicine. For more visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠stateofhealth.care⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠


FOLLOW US

More episodes from "State of Health"